×
App Icon
The Standard e-Paper
Informed Minds Prefer The Standard
★★★★ - on Play Store
Download Now

Covid-19 pill Paxlovid moves closer to full approval

Vocalize Pre-Player Loader

Audio By Vocalize

Doses of the anti-viral drug Paxlovid are displayed in New York, on August 1, 2022. [AP photo]

Pfizer's COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration.

The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the final say on giving Pfizer's drug full approval and is expected to decide by May.

Get Full Access for Ksh299/Week.
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
Football
Title-hungry Leopards seek to bounce back to winning ways
Golf
Magical Kenya Open: Jastas Madoya reveals what fuels his passion for golf
Olympics
NOC-K signs strategic MoU with Japanese Olympic Committee
Unique Sports
Youthful Kinoti Kiara crowned African fencing champion